A human memory T cell subset with stem cell–like properties

Gattinoni, Luca, Lugli, Enrico, Ji, Yun, Pos, Zoltan, Paulos, Chrystal M, Quigley, Máire F, Almeida, Jorge R, Gostick, Emma +9 more·2011·Nature Medicine
DOI 10.1038/nm.2446

Cited by (1,001)

Items 101–200 of 1,001

  1. Long-Term Antiretroviral Treatment Initiated at Primary HIV-1 Infection Affects the Size, Composition, and Decay Kinetics of the Reservoir of HIV-1-Infected CD4 T Cells
    Maria José Buzón, Enrique Martín‐Gayo, Florencia Pereyra, Zhengyu Ouyang, Hong Sun, Jonathan Z. Li, Michael J. Piovoso, Amy Shaw, Judith Dalmau, Nadine Zangger et al. · 2014 · Journal of Virology
  2. Eradicating HIV-1 infection: seeking to clear a persistent pathogen
    Nancie M. Archin, Julia Sung, Carolina Garrido, Natalia Soriano-Sarabia, David M. Margolis · 2014 · Nature Reviews Microbiology
  3. Age-Related Decline in Primary CD8+ T Cell Responses Is Associated with the Development of Senescence in Virtual Memory CD8+ T Cells
    Quinn, Kylie M., Fox, Annette, Harland, Kim L., Russ, Brendan E., Li, Jasmine, Nguyen, Thi H.O., Loh, Liyen, Olshanksy, Moshe, Naeem, Haroon, Tsyganov, Kirill et al. · 2018 · Cell Reports
  4. Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
    Paul W. Shafer, Lauren K. Somes, Valentina Hoyos · 2022 · Frontiers in Immunology
  5. Glypican-3–Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma
    Sai Arun Batra, Purva Rathi, Linjie Guo, Amy N. Courtney, Julien Fleurence, Julien C. Balzeau, Rahamthulla S. Shaik, Thao Phuong Nguyen, Meng‐Fen Wu, Shaun Bulsara et al. · 2020 · Cancer Immunology Research
  6. Phase I Study of Chimeric Antigen Receptor–Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract Cancers
    Yelei Guo, Kaichao Feng, Yang Liu, Zhiqiang Wu, Hanren Dai, Qingming Yang, Yao Wang, Hejin Jia, Weidong Han · 2017 · Clinical Cancer Research
  7. Driving gene-engineered T cell immunotherapy of cancer
    Laura A Johnson, Carl H. June · 2016 · Cell Research
  8. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis
    Teresa Prezzemolo, Giuliana Guggino, Marco Pio La Manna, Diana Di Liberto, Francesco Dieli, Nadia Caccamo · 2014 · Frontiers in Immunology
  9. Adoptive Immunotherapy for Cancer or Viruses
    Marcela Valderrama Maus, Joseph A. Fraietta, Bruce L. Levine, Michael D. Kalos, Yangbing Zhao, Carl H. June · 2014 · Annual Review of Immunology
  10. Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy
    Klaus Okkenhaug, Mariona Graupera, Bart Vanhaesebroeck · 2016 · Cancer Discovery
  11. The full spectrum of human naive T cells
    Theo van den Broek, José A. M. Borghans, Femke van Wijk · 2018 · Nature reviews. Immunology
  12. Precursors of human CD4 <sup>+</sup> cytotoxic T lymphocytes identified by single-cell transcriptome analysis
    Patil, Veena S., Madrigal, Ariel, Schmiedel, Benjamin J., Clarke, James, O’Rourke, Patrick, de Silva, Aruna D., Harris, Eva, Peters, Bjoern, Seumois, Gregory, Weiskopf, Daniela et al. · 2018 · Science Immunology
  13. Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infection
    Kyla D. Omilusik, J. Adam Best, Bingfei Yu, Steven Goossens, Alexander Weidemann, Jessica V. Nguyen, Eve Seuntjens, Agata Stryjewska, Christiane Zweier, Rahul Roychoudhuri et al. · 2015 · The Journal of Experimental Medicine
  14. Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
    Thinle Chodon, Begoña Comı́n-Anduix, Bartosz Chmielowski, Richard Chikara Koya, Zhongqi Wu, Martin Auerbach, Charles Ng, Earl V Avramis, Elizabeth Seja, Arturo Villanueva et al. · 2014 · Clinical Cancer Research
  15. Naïve T-cell Deficits at Diagnosis and after Chemotherapy Impair Cell Therapy Potential in Pediatric Cancers
    Rajat Kumar Das, Lauren M. Vernau, Stephan A. Grupp, David Maxwell Barrett · 2019 · Cancer Discovery
  16. Effector, Memory, and Dysfunctional CD8+T Cell Fates in the Antitumor Immune Response
    John Reiser, Arnob Banerjee · 2016 · Journal of Immunology Research
  17. CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome
    Silvia Arcangeli, Camilla Bove, Claudia Mezzanotte, Barbara Camisa, Laura Falcone, Francesco Manfredi, Eugenia Bezzecchi, Rita El Khoury, Rossana Norata, Francesca Sanvito et al. · 2022 · Journal of Clinical Investigation
  18. Inhibitory Receptors Beyond T Cell Exhaustion
    Silvia A. Fuertes Marraco, Natalie J. Neubert, Grégory Verdeil, Daniel E. Speiser · 2015 · Frontiers in Immunology
  19. Memory T cell–driven differentiation of naive cells impairs adoptive immunotherapy
    Christopher Austin Klebanoff, Christopher D. Scott, Anthony Joseph Leonardi, Tori N. Yamamoto, Anthony C. Cruz, Claudia Ouyang, Madhu Ramaswamy, Rahul Roychoudhuri, Yun Ji, Robert L Eil et al. · 2015 · Journal of Clinical Investigation
  20. Genetically engineered T cells for cancer immunotherapy
    Dan Li, Xue Li, Wei-Lin Zhou, Yong Huang, Xiao Liang, Lin Jiang, Xiao Yang, Jie Sun, Zonghai Li, Weidong Han et al. · 2019 · Signal Transduction and Targeted Therapy
  21. Cellular networks controlling T cell persistence in adoptive cell therapy
    Jack D. Chan, Junyun Lai, Clare Y. Slaney, Axel Kallies, Paul A. Beavis, Phillip Kevin Darcy · 2021 · Nature reviews. Immunology
  22. Tuning of Antigen Sensitivity by T Cell Receptor-Dependent Negative Feedback Controls T Cell Effector Function in Inflamed Tissues
    Tetsuya Honda, Jackson G. Egen, Tim Lämmermann, Wolfgang Kastenmüller, Parizad Torabi‐Parizi, Ronald N. Germain · 2014 · Immunity
  23. Developing neoantigen-targeted T cell–based treatments for solid tumors
    Tori N. Yamamoto, Rigel J. Kishton, Nicholas P. Restifo · 2019 · Nature Medicine
  24. Comprehensive Phenotyping of T Cells Using Flow Cytometry
    Charlotte M. Mousset, Willemijn A. Hobo, Rob Woestenenk, Frank W. M. B. Preijers, Harry Dolstra, Anniek B. van der Waart · 2019 · Cytometry Part A
  25. Metabolic Control of CD8+ T Cell Fate Decisions and Antitumor Immunity
    Lianjun Zhang, Pedro J. Romero · 2017 · Trends in Molecular Medicine
  26. The epigenetic control of stemness in CD8 + T cell fate commitment
    Luigia Pace, Christel Goudot, Elina Zueva, Paul Gueguen, Nina Burgdorf, Joshua J. Waterfall, Jean‐Pierre Quivy, Geneviève Almouzni, Sebastián Amigorena · 2018 · Science
  27. BNT162b2 vaccination induces durable SARS-CoV-2–specific T cells with a stem cell memory phenotype
    Gisella Guerrera, Mario Picozza, Silvia D’Orso, Roberta Placido, Marta Pirronello, Alice Verdiani, Andrea Termine, Carlo Fabrizio, Flavia Giannessi, Manolo Sambucci et al. · 2021 · Science Immunology
  28. Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity
    Jason Ross, Lara M. Myers, Joseph J. Noh, Madison M. Collins, Aaron Carmody, Ronald J. Messer, Erica Dhuey, Kim J. Hasenkrug, Irving L. Weissman · 2024 · Nature
  29. SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells
    Jae Hyung Jung, Min‐Seok Rha, Moa Sa, Hee Kyoung Choi, Ji Hoon Jeon, Hyeri Seok, Dae Won Park, Su‐Hyung Park, Hye Won Jeong, Won Suk Choi et al. · 2021 · Nature Communications
  30. Age related human T cell subset evolution and senescence
    Li, Mingde, Yao, Danlin, Zeng, Xiangbo, Kasakovski, Dimitri, Zhang, Yikai, Chen, Shaohua, Zha, Xianfeng, Li, Yangqiu, Xu, Ling · 2019 · Immunity &amp; Ageing
  31. Memory T cell, exhaustion, and tumor immunity
    Makoto Ando, Minako Ito, Tanakorn Srirat, Taisuke Kondo, Akihiko Yoshimura · 2019 · Immunological Medicine
  32. The precursors of CD8+ tissue resident memory T cells: from lymphoid organs to infected tissues
    Kok, Lianne, Masopust, David, Schumacher, Ton N. · 2022 · Nature Reviews Immunology
  33. TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy
    Eugene Y. Chiang, Ira Mellman · 2022 · Journal for ImmunoTherapy of Cancer
  34. ‘Stem-like’ precursors are the fount to sustain persistent CD8+ T cell responses
    Dietmar Zehn, Robert Thimme, Enrico Lugli, Gustavo Pereira de Almeida, Annette Oxenius · 2022 · Nature Immunology
  35. CAR therapy: the CD19 paradigm
    Michel Sadelain · 2015 · Journal of Clinical Investigation
  36. Lineage relationship of effector and memory T cells
    Nicholas P. Restifo, Luca Gattinoni · 2013 · Current Opinion in Immunology
  37. Role of memory T cell subsets for adoptive immunotherapy
    Dirk Hans Busch, Simon P. Fräßle, Daniel Sommermeyer, Veit R. Buchholz, Stanley R. Riddell · 2016 · Seminars in Immunology
  38. PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19
    Min‐Seok Rha, Hye Won Jeong, J.H. Ko, Seong Jin Choi, In‐Ho Seo, Jeong Seok Lee, Moa Sa, A. Reum Kim, Eun‐Jeong Joo, Jin Young Ahn et al. · 2020 · Immunity
  39. The role of cytokines in T‐cell memory in health and disease
    Miro E. Raeber, Yves Zurbuchen, Daniela Impellizzieri, Onur Boyman · 2018 · Immunological Reviews
  40. CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells
    In-Young Jung, Yoon-Young Kim, Ho-Sung Yu, Myoungsoo Lee, Seokjoong Kim, Jung‐Min Lee · 2018 · Cancer Research
  41. Canonical and Non-Canonical Wnt Signaling in Immune Cells
    Chae, Wook-Jin, Bothwell, Alfred L.M. · 2018 · Trends in Immunology
  42. The journey of CAR-T therapy in hematological malignancies
    Junru Lu, Guan Jiang · 2022 · Molecular Cancer
  43. Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside Efficacy
    Shivani Srivastava, Stanley R. Riddell · 2018 · The Journal of Immunology
  44. Long-lasting stem cell–like memory CD8 <sup>+</sup> T cells with a naïve-like profile upon yellow fever vaccination
    Fuertes Marraco, Silvia A., Soneson, Charlotte, Cagnon, Laurène, Gannon, Philippe O., Allard, Mathilde, Maillard, Samia Abed, Montandon, Nicole, Rufer, Nathalie, Waldvogel, Sophie, Delorenzi, Mauro et al. · 2015 · Science Translational Medicine
  45. Memory CD8+ T cell responses to cancer
    Jichang Han, Nikhil Khatwani, Tyler G. Searles, Mary Jo Turk, Christina Vadala Angeles · 2020 · Seminars in Immunology
  46. Stem-like exhausted and memory CD8+ T cells in cancer
    Thomas Gebhardt, Simone L. Park, Ian A. Parish · 2023 · Nature reviews. Cancer
  47. Understanding HIV Latency: The Road to an HIV Cure
    Matthew S. Dahabieh, Emilie Battivelli, Eric M. Verdin · 2015 · Annual Review of Medicine
  48. Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways
    Jian Yuan Huang, Michelle Nguyen-McCarty, Elizabeth Olson Hexner, Gwenn A. Danet-Desnoyers, Peter S. Klein · 2012 · Nature Medicine
  49. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models
    Yuki Kagoya, Munehide Nakatsugawa, Yūki Yamashita, Toshiki Ochi, Tingxi Guo, Mark Anczurowski, Kayoko Saso, Marcus Otho Butler, C.H. Arrowsmith, Naoto Hirano · 2016 · Journal of Clinical Investigation
  50. PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells
    Wenting Zheng, Carol Elaine O'Hear, Rajshekhar Alli, Jacob H. Basham, Hossam Aly Abdelsamed, Lance E. Palmer, Lindsay L. Jones, Ben Youngblood, Terrence L. Geiger · 2018 · Leukemia
  51. PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells
    Sebastian B. Lacher, Janina Dörr, Gustavo Pereira de Almeida, Julian Hönninger, Felix Bayerl, Anna Hirschberger, Anna‐Marie Pedde, Philippa Meiser, Lukas Ramsauer, Thomas J Rudolph et al. · 2024 · Nature
  52. Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
    Andras Attila Heczey, Xin Yi Xu, Amy N. Courtney, Gengwen Tian, Gabriel A. Barragán, Linjie Guo, Claudia Martínez-Amador, Nisha Ghatwai, Purva Rathi, Michael S. Wood et al. · 2023 · Nature Medicine
  53. T cell factor 1: A master regulator of the T cell response in disease
    Escobar, Giulia, Mangani, Davide, Anderson, Ana C. · 2020 · Science Immunology
  54. Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell Therapy
    Gregory M. Chen, Changya Chen, Rajat Kumar Das, Peng Gao, Chia‐Hui Chen, Shovik Bandyopadhyay, Yangyang Ding, Yasin Uzun, Wenbao Yu, Qin Zhu et al. · 2021 · Cancer Discovery
  55. A guide to adaptive immune memory
    Nora Lam, Yoon Seung Lee, Donna L. Färber · 2024 · Nature reviews. Immunology
  56. CAR-T cell performance: How to improve their persistence?
    López-Cantillo, Gina, Urueña, Claudia, Camacho, Bernardo Armando, Ramírez-Segura, Cesar · 2022 · Frontiers in Immunology
  57. Reassessing target antigens for adoptive T-cell therapy
    Christian S. Hinrichs, Nicholas P. Restifo · 2013 · Nature Biotechnology
  58. Fine-tuning the CAR spacer improves T-cell potency
    Norihiro Watanabe, Pradip Bajgain, Sujita Sukumaran, Salma Ansari, Helen Elisabeth Heslop, Cliona M. Rooney, Malcolm K. Brenner, Ann Marie Leen, Juan F. Vera · 2016 · OncoImmunology
  59. Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells
    Petra Schuberth, Christian Hagedorn, Shawn M. Jensen, Pratiksha Gulati, Maries F. van den Broek, Axel Mischo, Alex Soltermann, Astrid Jüngel, Osiris Marroquin Belaunzaran, Rolf Arno Stahel et al. · 2013 · Journal of Translational Medicine
  60. Chimeric Antigen Receptors With Mutated IgG4 Fc Spacer Avoid Fc Receptor Binding and Improve T Cell Persistence and Antitumor Efficacy
    Mahesh Jonnalagadda, Armen Mardiros, Ryan Z. Urak, Xiuli Wang, Lauren J Hoffman, Alyssa Bernanke, Wen-Chung Chang, William S Bretzlaff, Renate Starr, Saul J. Priceman et al. · 2014 · Molecular Therapy
  61. Designing chimeric antigen receptors to effectively and safely target tumors
    Michael C. Jensen, Stanley R. Riddell · 2015 · Current Opinion in Immunology
  62. Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
    Hao Wang, Gurbakhash Kaur, Alexander I. Sankin, Fuxiang Chen, Fangxia Guan, Xingxing Zang · 2019 · Journal of Hematology & Oncology
  63. The Effects of TLR Activation on T-Cell Development and Differentiation
    Bo Jin, Tao Sun, Xiaohong Yu, Yingxiang Yang, Anthony E. T. Yeo · 2012 · Clinical and Developmental Immunology
  64. Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells
    Enrico Lugli, Luca Gattinoni, Alessandra Roberto, Domenico Mavilio, David A. Price, Nicholas P. Restifo, Mario Roederer · 2012 · Nature Protocols
  65. Towards a commercial process for the manufacture of genetically modified T cells for therapy
    A. Kaiser, Mario Assenmacher, B Schröder, M Meyer, Rimas J. Orentas, Ulf Bethke, Boro Dropulić · 2015 · Cancer Gene Therapy
  66. Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells
    Yun Ji, Zoltán Pós, Mahadev Rao, Christopher Austin Klebanoff, Zhiya Yu, Madhusudhanan Sukumar, Robert N. Reger, Douglas C. Palmer, Zachary A. Borman, Pawel J. Muranski et al. · 2011 · Nature Immunology
  67. Impact of Manufacturing Procedures on CAR T Cell Functionality
    Norihiro Watanabe, Feiyan Mo, Mary Kathryn McKenna · 2022 · Frontiers in Immunology
  68. Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT
    Maddalena Noviello, Francesco Manfredi, Eliana Ruggiero, Tommaso Perini, Giacomo Oliveira, Filippo Cortesi, Pantaleo De Simone, Cristina Toffalori, Valentina Gambacorta, Raffaella Greco et al. · 2019 · Nature Communications
  69. Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation
    Daniela Pais Ferreira, Joana Gomes da Silva, Tania Wyss, Silvia A. Fuertes Marraco, Léonardo Scarpellino, Mélanie Charmoy, Roeltje R. Maas, Imran Siddiqui, Li Tang, Johanna A. Joyce et al. · 2020 · Immunity
  70. Effective response and delayed toxicities of refractory advanced diffuse large B-cell lymphoma treated by CD20-directed chimeric antigen receptor-modified T cells.
    Yao Wang, Wen-Ying Zhang, Qing-wang Han, Yang Liu, Han-Ren Dai, Ye-Lei Guo, J. Bo, Hui Fan, Yan Zhang, Ya-Jing Zhang et al. · 2014 · Clinical Immunology
  71. Activation or exhaustion of CD8+ T cells in patients with COVID-19
    Min‐Seok Rha, Eui‐Cheol Shin · 2021 · Cellular and Molecular Immunology
  72. Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy
    Bojun Wang, Tian Tian, Karl‐Henning Kalland, Xisong Ke, Yi Qu · 2018 · Trends in Pharmacological Sciences
  73. Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
    Sanghyun Peter Kim, Nolan R. Vale, Nikolaos Zacharakis, Sri Krishna, Zhiya Yu, Billel Gasmi, Jared J. Gartner, Sivasish Sindiri, Parisa Malekzadeh, Drew C. Deniger et al. · 2022 · Cancer Immunology Research
  74. A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer
    Daniel Abate‐Daga, Kiran H. Lagisetty, Eric Tran, Zhili Zheng, Luca Gattinoni, Zhiya Yu, William R. Burns, Anne M. Miermont, Yaroslav Teper, Udo Rudloff et al. · 2014 · Human Gene Therapy
  75. Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor
    Anna Pasetto, Alena Gros, Paul F. Robbins, Drew C. Deniger, Todd D. Prickett, Rodrigo Matus‐Nicodemos, Daniel C. Douek, Bryan Howie, Harlan S. Robins, Maria R. Parkhurst et al. · 2016 · Cancer Immunology Research
  76. Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability
    Sònia Guedan, Aviv Madar, Victoria Casado‐Medrano, Carolyn E. Shaw, Anna Wing, Fang Liu, Regina M. Young, Carl H. June, Avery D. Posey · 2020 · Journal of Clinical Investigation
  77. Androgen receptor-mediated CD8+ T cell stemness programs drive sex differences in antitumor immunity
    Chao Yang, Jingsi Jin, Yuanqin Yang, Hongxiang Sun, Lingling Wu, Mingyi Shen, Xiaochuan Hong, Wenwen Li, Lu Lu, Dongqing Cao et al. · 2022 · Immunity
  78. CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
    Hannah M. Knochelmann, Aubrey S. Smith, Connor J. Dwyer, Megan M. Wyatt, Shikhar Mehrotra, Chrystal Mary Paulos · 2018 · Frontiers in Immunology
  79. An atlas of cells in the human tonsil
    Ramon Massoni-Badosa, Sergio Aguilar-Fernández, Juan Camilo Nieto, Paula Soler-Vila, Marc Elosua-Bayés, Doménica Marchese, Marta Kulis, Amaia Vilas‐Zornoza, Marco Matteo Bühler, Sonal Rashmi et al. · 2024 · Immunity
  80. The activation of the adaptive immune system: Cross-talk between antigen-presenting cells, T cells and B cells
    Joke M. M. den Haan, Ramon Arens, Menno C. van Zelm · 2014 · Immunology Letters
  81. Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells
    Patrick L. Collins, Marina Cella, Sofia I. Porter, Shasha Li, Greer L. Gurewitz, Henoch Sangjoon Hong, R. Paul Johnson, Eugene M. Oltz, Marco Colonna · 2018 · Cell
  82. Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR
    Dana Stenger, Tanja A. Stief, Theresa Kaeuferle, Semjon Manuel Willier, Felicitas Rataj, Kilian Schober, Binje Vick, Ramin Lotfi, Beate Wagner, Thomas G. P. Grünewald et al. · 2020 · Blood
  83. The transcription factor c-Myb regulates CD8+ T cell stemness and antitumor immunity
    Sanjivan Gautam, Jessica Fioravanti, Wei Zhu, John Brian Le Gall, Philip Z. Brohawn, Neal E. Lacey, Jinhui Hu, James D. Hocker, Nga Voong Hawk, Veena Kapoor et al. · 2019 · Nature Immunology
  84. Human memory T cells with a naive phenotype accumulate with aging and respond to persistent viruses
    Pulko, Vesna, Davies, John S, Martinez, Carmine, Lanteri, Marion C, Busch, Michael P, Diamond, Michael S, Knox, Kenneth, Bush, Erin C, Sims, Peter A, Sinari, Shripad et al. · 2016 · Nature Immunology
  85. CAR T Cell Therapy: A Game Changer in Cancer Treatment
    Hilde Almåsbak, Tanja Aarvak, Mohan C. Vemuri · 2016 · Journal of Immunology Research
  86. MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects
    Vivek Verma, Nazli Jafarzadeh, Shannon Kathryn Boi, Subhadip Kundu, Zhinuo Jiang, Yiping Fan, Jose Lopez, Rahul M. Nandre, Peng Zeng, Fatmah Alolaqi et al. · 2020 · Nature Immunology
  87. An engineered IL-2 partial agonist promotes CD8+ T cell stemness
    Fei Mo, Zhiya Yu, Peng Li, Jangsuk Oh, Rosanne J. Spolski, Liang Zhao, Caleb R. Glassman, Tori N. Yamamoto, Yun Chen, Filip Gołębiowski et al. · 2021 · Nature
  88. Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor–Redirected T Cells Against Multiple Myeloma
    Xiuli Wang, Miriam Walter, Ryan Z. Urak, Lihong Weng, Christian Huynh, Laura Lim, ChingLam W. Wong, Wen-Chung Chang, Sandra H. Thomas, James F. Sanchez et al. · 2017 · Clinical Cancer Research
  89. The function and dysfunction of memory CD 8+ T cells in tumor immunity
    James L. Reading, Felipe Gálvez‐Cancino, Charles Swanton, Álvaro Lladser, Karl S. Peggs, Sergio A. Quezada · 2018 · Immunological Reviews
  90. Chimeric Antigen Receptor– and TCR-Modified T Cells Enter Main Street and Wall Street
    David Maxwell Barrett, Stephan A. Grupp, Carl H. June · 2015 · The Journal of Immunology
  91. CAR–T cells and solid tumors: tuning T cells to challenge an inveterate foe
    David Edward Gilham, Reno Debets, Martin A. Pulè, Robert E. Hawkins, Hinrich Abken · 2012 · Trends in Molecular Medicine
  92. Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy
    Yuki Kagoya, Tingxi Guo, Brian Yeung, Kayoko Saso, Mark Anczurowski, Chung-Hsi Wang, Kenji Murata, Kenji Sugata, Hiroshi Saijo, Yukiko Matsunaga et al. · 2020 · Cancer Immunology Research
  93. Functional T cells are capable of supernumerary cell division and longevity
    Andrew G. Soerens, Marco Künzli, Clare F. Quarnstrom, Milcah C. Scott, Lee Swanson, JJ. Locquiao, Hazem E. Ghoneim, Dietmar Zehn, Ben Youngblood, Vaiva Vezys et al. · 2023 · Nature
  94. In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells
    Biasco, Luca, Scala, Serena, Basso Ricci, Luca, Dionisio, Francesca, Baricordi, Cristina, Calabria, Andrea, Giannelli, Stefania, Cieri, Nicoletta, Barzaghi, Federica, Pajno, Roberta et al. · 2015 · Science Translational Medicine
  95. Reinforce the antitumor activity of CD 8 + T cells via glutamine restriction
    Shogo Nabe, Takeshi Yamada, Junpei Suzuki, Koji Toriyama, Toshiaki Yasuoka, Makoto Kuwahara, Atsushi Shiraishi, Katsuto Takenaka, Masaki Yasukawa, Masakatsu Yamashita · 2018 · Cancer Science
  96. Depletion of BATF in CAR-T cells enhances antitumor activity by inducing resistance against exhaustion and formation of central memory cells
    Xingying Zhang, Chenze Zhang, Miaomiao Qiao, Chen Cheng, Na Tang, Shan Lu, Wen Ce Sun, Beilei Xu, Yuanwei Cao, Xiaofei Wei et al. · 2022 · Cancer Cell
  97. T lymphocyte subsets in cancer immunity: Friends or foes
    Dounia Chraa, Asmâa Naim, Daniel Olive, Abdallah Badou · 2018 · Journal of Leukocyte Biology
  98. CAR T-cell therapy for multiple myeloma: state of the art and prospects
    Niels W.C.J. van de Donk, Saad Z. Usmani, Kwee Yong · 2021 · The Lancet Haematology
  99. Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs
    Eleanor M. P. Wilson, Irini Sereti · 2013 · Immunological Reviews
  100. Identification and characterization of HIV-specific resident memory CD8 + T cells in human lymphoid tissue
    Marcus Buggert, Son Nguyen, Gonzalo Salgado Montes de Oca, Bertram Bengsch, Samuel W. Darko, Amy Ransier, Emily R Roberts, Daniel Del Alcazar, Irene Bukh Brody, Laura A. Vella et al. · 2018 · Science Immunology